In this study, we provide the first evidence demonstrating that CTSE overexpression is significantly correlated with inferior clinical outcomes and acts as an unfavorable predictive biomarker for rectal cancer patients treated with preoperative CCRT. This evidence concerns the gene CTSE and rectal cancer.